Investigate.Inform. Inspire
Dear Nadia, My son was diagnosed with T1 when he was eight years old. He has been living in Saudi Arabia and getting excellent medical care from the time of his diagnosis. He started using an insulin pump at the age of 9. He is now going to Pomona, California and enrolling in intensive English courses. I would like your recommendations for an excellent T1
Read more
Dear Nadia: I was at a restaurant. After we’d ordered, I tested and dosed. I received a hostile look from a lady at another table. I smiled and said, “I could drop my trousers and inject in my butt, if you’d prefer.” A few moments later a waiter came up and asked me to leave. On the way out I stopped at the hostile
Read more
The FDA reminds us why sharing insulin pens may create long terms health concerns. While some people do save on costs when reusing and or sharing insulin pens, the possible long term complications are not worth the savings. By Food and Drug Administration The Food and Drug Administration (FDA) is reminding health care professionals and patients that insulin pens and insulin cartridges should not be
Read more
The Institute for Safe Medication Practices performs a watchdog function when it comes to monitoring errors in prescribing and administering drugs throughout the U.S. healthcare system. It recently reported that one hospital has had to test 4,200 patients after learning that they may have received insulin injections from insulin pens previously used on other patients. The hospital, which is not named in the ISMP report,
Read more
Plainsboro, N.J.–Novo Nordisk has announced the U.S. launch of its NovoPen Echo® insulin delivery device. It is the first and only pen device available in this country with half-unit dosing and a memory function that records the dose and time passed since the last injection. “We believe this pen can help patients fine-tune their dosing while offering added reassurance they are managing their diabetes appropriately,”
Read more
The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on the market to combine half-unit dosing with a memory function to help patients manage their diabetes. Manufacturer Novo Nordisk says the pen represents a significant milestone in insulin delivery, especially for children with diabetes and their caregivers. “It can offer caregivers increased confidence that their
Read more